Form 8.3 - Avadel Pharmaceuticals Plc

2025-11-03 09:31:48

(MENAFN- GlobeNewsWire - Nasdaq) FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORM A TION

Name of person dealing (Note 1)	State Street Global Advisors & Affiliates
Company dealt in	Avadel Pharmaceuticals plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	$0.01 ordinary shares
Date of dealing	31^st October 2025

2. INTERESTS AND SHORT POSITIONS
(110) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long	Short
	Number	(%)	Number	(%)
(1) Relevant securities	2,282,394	2.34324%
(2) Derivatives (other than options)	N/A	N/A
(3) Options and agreements to purchase/sell	N/A	N/A
T otal	2,282,394	2.34324%

(b) Interests and short positions in relevant securities of the compan y , other than the class dealt in (Note 3)

Class of relevant security:	Long	Short
	Number	(%)	Number	(%)
(1) Relevant securities	N/A
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	N/A
T otal	N/A

3. DEALINGS (Note 4)
(110) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit (Note 5)
Purchase	700	18.89
Purchase	400	18.89
Sale	700	18.89
Sale	4,100	18.89

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit (Note 5)
N/A

(c) Options transactions in respect of existing relevant securities

(i) W riting, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type , e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)
N/A

(ii) Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)
N/A

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)
N/A

4. OTHER INFORM A TION
Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

N/A

Is a Supplemental Form 8 attached? (Note 9)
NO
Date of disclosure
3^rd November 2025

Contact name
Divya K
T elephone number

+918067452364

If a connected EFM, name of offeree/offeror with which connected
N/A
If a connected EFM, state nature of connection (Note 10)
N/A

MENAFN03112025004107003653ID1110287231

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.